Galderma Shares Plunge After FDA Rejects Botox Rival Relfydess
Galderma shares sank after the FDA rejected its Botox rival Relfydess, delaying U.S. market entry and strengthening AbbVie's grip on the aesthetics…
Galderma shares sank after the FDA rejected its Botox rival Relfydess, delaying U.S. market entry and strengthening AbbVie's grip on the aesthetics…
Futu and Up Fintech saw a surge in options activity before a regulatory crackdown triggered a slump in their shares, highlighting the…
Julius Baer stock dropped as net new money fell short of estimates, outweighing an upbeat profit outlook and spotlighting the bank's weak…
Deere (DE) stock declined sharply as enduring farmer challenges depressed agricultural equipment demand, though the company's construction business buoyed its full-year earnings…